Patient Pathfinder: Clinical Trials
Clinical Trials for Transthyretin Amyloid Cardiomyopathy
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 32 active Transthyretin Amyloid Cardiomyopathy trials
APOLLO-B: A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)
Study Type: Interventional Phase 3
Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR
Study Type: Interventional Phase 2
Screening for Cardiac Amyloidosis With Nuclear Imaging for Minority Populations
Study Type: Observational
Open-Label Study of AG10 in Patients With Cardiomyopathy
Study Type: Interventional Phase 2
Safety, Efficacy, and Pharmacokinetics of Tafamidis in Patients With Transthyretin-mediated Amyloidosis Post Orthotopic Heart Transplantation
Study Type: Interventional Phase 4
HELIOS-A: A Study of Vutrisiran (ALN-TTRSC02) in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis)
Study Type: Interventional Phase 3
Intracardiac Flow Assessment in Cardiac Amyloidosis
Study Type: Observational
A Clinical Study to Characterize Adverse Events Occurring Within One Day of TEGSEDI Administration to Adult Patients With hATTR-PN
Study Type: Interventional Phase 4
There are 32 active Transthyretin Amyloid Cardiomyopathy trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now